Articles / Reliable information on COVID vaccine required for Aussie GPs
0 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
As millions of extra Pfizer vaccines arrive on our doorstep, information on the COVID-19 vaccine rollout remains cloudy.
A new Healthed survey of almost 1000 practising GPs conducted only two weeks ago suggests GPs are unlikely to be trying to convince patients under 60 to have the AstraZeneca vaccine instead of Pfizer.
Almost half of the respondents (45.3%) believed there was not enough publicly available information from reliable sources to ensure patients under 60 could make an informed choice about having the AstraZeneca vaccine.
In addition, while more than three-quarters of the doctors in the survey said that these under-60 year old patients would most likely rely on information from their GP to make the decision about whether or not to have the AZ vaccine rather than wait for the Pfizer vaccine, almost one third of GPs (31.27%) said they did not feel sufficiently informed themselves to be able to adequately help their patients in this decision.
Autism Spectrum Disorder in Children
Early Menopause
Donanemab – A GP Guide to Anti-Amyloid Therapies
LDL and Cardiovascular Disease
Within the next 12 months
Within the next 3 years
Within the next 5 years
Within the next 10 years
More than 10 years
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.
Menopause and MHT
Multiple sclerosis vs antibody disease
Using SGLT2 to reduce cardiovascular death in T2D
Peripheral arterial disease